Growth factors of the glial cell line-derived neurotrophic factor (GDNF) family control the dierentiation of neuronal cells of the central and peripheral nervous systems. Intracellular signalling of these growth factors is, at least in part, mediated by activation of the RET receptor tyrosine kinase. Here, we demonstrate that GDNF triggering inhibits the proliferation of the embryonal carcinoma cell line NT2/D1. This antiproliferative eect is accompanied by down-regulation of the SSEA-3 antigen, a marker typical of undierentiated NT2/D1 cells. We show that these eects are mediated by activation of RET signalling. The block of RET by a kinase-de®cient dominant negative mutant impairs GDNF-dependent growth inhibition, whereas the adoptive expression of a constitutively active RET, the RET-MEN2A oncogene, promotes eects similar to those exerted by GDNF. We show that RET signalling increases the expression of the cyclin-dependent kinase inhibitor p27 kip1 in NT2/D1 cells. Both DNA synthesis inhibition and SSEA-3 down-regulation are prevented if p27 kip1 expression is blocked by an antisense construct, which demonstrates that RET-triggered eects are mediated by p27 kip1 .
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Introduction
The GDNF protein family consists of four members: glial cell line-derived neurotrophic factor (GDNF), neurturin (NTN), persephin (PSP) and artemin (ART). These neurotrophins play a crucial role in the dierentiation, proliferation and survival of neurons of the peripheral and central nervous system (Airaksinen et al., 1999) . The GDNF proteins signal through a multi-component receptor complex consisting of ligand-binding GDNF family receptors, i.e. asubunits (GFRa) and RET receptor tyrosine kinase. GFRas are glycosyl-phosphatidylinositol (GPI)-linked polypeptides; to date, four GFRa proteins, termed GFRas1, 2, 3 and 4 have been identi®ed. GFRa1, 2, 3 and 4 bind predominantly GDNF, NTN, ART and PSP, respectively. RET functions as a common intracellular signal-transducing component in conjunction with each of the GFRas (Airaksinen et al., 1999) . GFRa also plays a role in recruiting RET to lipid rafts, an event that is required for eective signalling (Tansey et al., 2000) . GFRas co-receptors may signal in the absence of RET; GDNF induces the phosphorylation of the cyclic AMP response element-binding protein (CREB) and c-fos transcription in neuronal precursors that express GFRa1 but not RET (Trupp et al., 1999) .
The GDNF-GFRas-RET system is crucial for the development of neuronal cells. Hirschsprung's disease, which is characterized by the lack of enteric innervation to the hindgut, arises from mutations that inactive RET (Pasini et al., 1995; Carlomagno et al., 1996) . Knock-out mice lacking GDNF, RET or GFRa1 fail to develop enteric neurons (Rosenthal, 1999) . RET triggering induces survival and dierentiation of neuroepithelial cell types (Califano et al., 1995; Jing et al., 1996; De Vita et al., 2000) . However, despite the body of information on the mechanisms of RETmediated signalling (van Weering and Bos, 1998) , the molecular pathways that trigger RET-mediated neuronal dierentiation remain obscure.
Inhibition of the progression through the cell cycle is a pre-requisite for cells to enter a program of terminal dierentiation. Indeed, neuronal cells respond to neurotrophic factors, such as nerve growth factor (NGF), by undergoing growth arrest and, then, proceeding to dierentiation . Nerve growth factor suppresses cell proliferation by reducing the activity of cyclin-dependent kinases (CDK) (Park et al., 1996) . CDK activity is modulated by the binding of positive (cyclins) and negative (CDK inhibitory proteins, CKI) regulatory subunits. Whereas the cellular level of CDK proteins varies little through the cell cycle, a rapid increase in cyclins and CKI subunits leads to progression and arrest of the cell cycle, respectively (Sherr and Roberts, 1999) . The CKI subunits p21 cip1 and p27 kip1 play a pivotal role in arresting cell in the G1 phase of the cell cycle (Sherr and Roberts, 1999) .
NTERA-2 clone D1 (NT2/D1) cells display characteristics of committed neuronal progenitors. NT2/D1 cells arrest growth and dierentiate into post-mitotic neurons upon treatment with retinoic acid (RA) (Andrews, 1984) . Retinoic acid-dierentiated NT2/D1 cells elaborate processes that dierentiate into axons and dendrites (Pleasure et al., 1992; Pleasure and Lee, 1993; Lee and Andrews, 1986; Simeone et al., 1990) . Furthermore, RA-treated NT2/D1 cells down-regulate expression of the SSEA-3 antigen and up-regulate the A2B5 antigen Chen et al., 1989; Baldassarre et al., 1997 Baldassarre et al., , 1999 . NT2/D1 cells transplanted into immunode®cient mice have been used as an in vivo model to study the formation and remodelling of the developing central nervous system (Miyazono et al., 1996) .
We report that GDNF induces DNA synthesis inhibition and reduced expression of the SSEA-3 marker in NT2/D1 cells. These eects are mimicked by the expression of the RET-MEN2A oncogene, but are blocked by a dominant-interfering RET mutant. p27 kip1 is a pivotal mediator of the eects induced by RET since inhibition of RET-dependent p27 kip1 accumulation impaired proliferative inhibition and SSEA-3 down-regulation in NT2/D1 cells.
Results
GDNF reduces growth rate and SSEA-3 antigen expression in NT2/D1 cells NT2/D1 cells were treated in parallel with GDNF (2 and 20 ng/ml) or RA (10 mM) for 7 days and the eects of both compounds on cell proliferation were determined by evaluating cell number at dierent time points. Growth rate was lower in GDNF-or RA-treated as compared with untreated cells ( Figure  1a) . Similar results were obtained by calculating the rate of bromodeoxyuridine (BrdU) incorporation, a measure of DNA synthesis. BrdU incorporation was signi®cantly lower in cells treated with GDNF (20 ng/ ml) for 3, 5 and 7 days (46, 33 and 32%, respectively), versus 60% for untreated cells). Inhibition of GDNF-mediated DNA synthesis was minor compared with that induced by RA (15% of cells incorporated BrdU after 7 days of RA treatment; data not shown). A representative microscopic ®eld is shown in Figure 1b .
In theory, GDNF may suppress NT2/D1 cell growth by arresting cell cycle progression or by increasing cell death. We therefore used¯ow cytometry to investigate the mechanism whereby GDNF suppressed growth in NT2/D1 cells. Asynchronously proliferating NT2/D1 cells were treated for 4, 7 and 15 days with 20 ng/ml of GDNF, labelled with propidium iodide and analysed with FACScan. Typically, 44% of proliferating NT2/ D1 cells were in the S phase compartment, whereas upon GDNF treatment, the percentage of cells in G1 increased and the percentage of cells in the S phase compartment was reduced (29% of S phase cells at 4 days of treatment, 26% of S phase cells at 7 days and 22% at 15 days of treatment, respectively). Results are summarized in Table 1 and a representative experiment is reported in Figure 1c .
We next analysed the eects exerted by GDNF on the dierentiation of NT2/D1 cells. Most NT2/D1 cells express the SSEA-3 antigen (64%, on average) but not the A2B5 antigen. The dierentiation induced by RA consists in the loss of SSEA-3 expression and in the appearance of A2B5 Chen et al., 1989; Baldassarre et al., 1997 Baldassarre et al., , 1999 . By indirect immuno¯uorescence (a representative ®eld is shown in Figure 1d ), we found that GDNF treatment (20 ng/ ml for 7 days) down-regulated the expression of SSEA-3; after GDNF stimulation only 28% of cells remained positive for SSEA-3 expression (Table 1) . However, unlike RA, GDNF did not up-regulate A2B5 or induce neurite extensions (not shown).
Subsequently, we determined GDNF-induced RET phosphorylation in NT2/D1 cells by immunoprecipitating the RET protein and staining the immunoblot with anti-phosphotyrosine antibodies. Treatment of NT2/ D1 cells with 100 ng/ml of GDNF for 10 min promptly induced RET phosphorylation (Figure 1e ). RET stimulation by GDNF was likely mediated by the GFRa1 co-receptor, because GFRas1 expression was detected in NT2/D1 cells by RT ± PCR (not shown).
Interestingly, GDNF treatment also reduced the tumorigenicity of NT2/D1 cells (not shown). These ®ndings indicate that GDNF, by reducing the rate of proliferation and the expression of the SSEA-3 antigen, reproduces in part the eects exerted by RA on NT2/ D1 cells.
GDNF-triggered growth inhibition of NT2/D1 cells is mediated by RET activation
We asked whether RET activation was necessary for GDNF to inhibit NT2/D1 cell growth. We ®rst investigated whether the impairment of RET signalling aected the antiproliferative activity exerted by GDNF. To this aim, we engineered a truncated RET mutant, RET(DK) (Figure 2a ). This truncated form of RET lacked the cytoplasmic catalytic domain; by dimerizing with the wild type RET, RET(DK) was predicted to prevent GDNF-induced RET transphosphorylation. The presence of a C-terminal tag (FLAG) discriminated the transfected RET(DK) from endogenous RET. In turn, RET(DK) does not interact with the anti-RET polyclonal antibody, which is directed against the RET kinase domain (see Materials and methods). COS-7 cells were transfected with the empty vector (LTR), RET(DK), RET and both RET and RET(DK) at dierent molar ratios (1 : 1 and 1 : 2); in all cases GFRa1 was co-transfected. Cells were treated with GDNF and lysed; protein extracts were immunoprecipitated with anti-RET followed by immunoblot with anti-phosphotyrosine. In the absence of RET(DK) expression, GDNF triggered RET phosphorylation ( Figure 2b ). RET(DK) reduced GDNFmediated phosphorylation of RET when the two plasmids were transfected at a 1 : 1 ratio. At a 1 : 2 ratio RET phosphorylation was almost abrogated (Figure 2b ), demonstrating that RET(DK) dominantly interferes with wild type RET stimulation. An immunoblot with anti-tag antibodies was performed to ascertain RET(DK) expression. Thus, to obtain cells that were unable to activate the RET tyrosine kinase, the RET(DK) mutant was transfected into NT2/D1 cells. Six G418 resistant clones that expressed the transfected construct, as shown by Western blot using anti-tag antibodies (Figure 2c ), were selected. The growth rate of three representative transfected clones, i.e. NT2-RET(DK)3, NT2-RET(DK)5 and NT2-RET(DK)8 in response to GDNF was compared with the growth rate of one vector-transfected clone used as a control. Flow cytometry showed that after 7 days of GDNF treatment (20 ng/ml), 29% of vector-transfected NT2/D1 cells were in S phase, whereas about 40% of NT2/D1-RET(DK) cells were in the S phase compartment (Table 1 and Figure 2d ). The analysis of BrdU incorporation yielded similar results (not shown). As expected, GDNF failed to induce SSEA-3 downregulation in NT2/D1-RET(DK) cells (the average results of four experiments are shown in Table 1 ). Figure 2e shows a representative ®eld.
Subsequently, we investigated whether RET activation was not only necessary but also sucient to inhibit the growth of NT2/D1 cells. To this aim, we transfected a constitutively activated RET-MEN2A mutant (RETC634Y) into NT2/D1 cells ( Figure 3a) . The C634Y mutation induces dimerization and constitutive activation of RET receptor mediated by the formation of aberrant disul®de-bonds . NT2/D1 cells were transiently transfected with RET-MEN2A or with the empty vector together with a pEGFP plasmid that encodes the auto¯uorescent eukaryotic green¯uorescent protein, to identify transfected cells. In this case we used the rate of BrdU incorporation as a measure of cell growth inhibition exerted by activated RET. Cells were plated onto coverslips and 48 h after transfection they were processed for indirect immuno¯uorescence to determine BrdU incorporation rate and SSEA-3 expression. At least 200 transfected (GFP-positive) cells were evaluated. Similarly to GDNF treatment, transfection of the RET-MEN2A mutant reduced BrdU incorporation: on average 56% of vector-transfected NT2/D1 cells incorporated BrdU, whereas only 23% of RET-MEN2A NT2/D1 cells incorporated BrdU (Table 2) .
Furthermore, RET-MEN2A suppressed SSEA-3 expression (Table 2) , although, like GDNF, it did not induce A2B5 up-regulation (not shown). Conversely, the kinase defective RET(DK) failed to induce growth arrest and SSEA-3 down-regulation; instead, it determined a slight increase of SSEA-3 levels compared with vectortransfected cells (Table 2 ). Figure 3b shows a representative experiment: control LTR plasmid did not modify SSEA-3 expression (®rst column), whereas RET-MEN2A induced a loss of SSEA-3 expression (second column, the green-transfected cell did not stain red).
SSEA-3 down-regulation was not observed in NT2/D1 cells transfected with RET(DK) mutant (third column, the green transfected cells are also red). Interestingly, consistent with the growth arresting eect, we were unable to select NT2/D1 cell clones stably expressing the activated RET-MEN2A mutant (not shown).
These ®ndings demonstrate that activation of the RET pathway in NT2/D1 cells is sucient to exert eects similar to those elicited by GDNF and that the functional integrity of the RET pathway is required for GDNF-induced growth inhibition and SSEA-3 downregulation.
GDNF and RET-MEN2A up-regulate p27 kip1 expression in NT2/D1 cells The growth and dierentiative eects exerted by RA or other dierentiative compounds in NT2/D1 cells are mediated by up-regulation of the cyclin-dependent kinase inhibitor p27 kip1 and subsequent inhibition of CDK2 activity (Baldassarre et al., 1999 (Baldassarre et al., , 2000 . Therefore, we investigated whether GDNF induces p27 kip1 expression. GDNF induced a threefold increase in p27 kip1 protein levels at day 7 of treatment ( Figure 4a ), but it did not aect the expression of cyclins and CDK or the expression of the other members of the Kip/cip family of inhibitors (p21 cip1 and p57 kip2 ) (not shown). To determine whether GDNF induced p27 expression at the mRNA or protein level, we performed RT ± PCR analysis at a low number of cycles (23) with p27 speci®c primers. As internal control, we used primers that ampli®ed GAPDH. RT ± PCR analysis demonstrated that GDNF did not induce an increase in the steady-state levels of p27 mRNA in NT2/D1 cells (Figure 4b ), which suggests that most p27 accumulation after GDNF treatment results from post-transcriptional mechanisms.
GDNF treatment resulted in a greater amount of p27 kip1 associated to CDK2 (2.3-and 3.2-fold at 5 and 7 days of treatment, respectively) ( Figure 4c ) and to CDK4 (1.4-and 2.7-fold at 5 and 7 days respectively) ( Figure 4d ) compared with cycling cells, as assessed by co-immunoprecipitation; the corresponding kinases activities were proportionally reduced (Figure 4c,d , lower panels).
Suppression of p27 kip1 expression impairs GDNF/RETmediated proliferative inhibition
We sought to obtain more direct evidence that p27 kip1 could be a downstream eector of the GDNF/RET signalling system. To this aim, we used the antisense methodology to suppress GDNF-and RET-MEN2A-induced expression of p27 kip1 . We generated NT2/D1-p27AS cell clones by transfecting a pCMV vector carrying the p27 kip1 cDNA in the antisense orientation. We selected several neomycin-resistant clones and chose three independent clones for further studies (NT2/D1-p27AS2.6, p27AS2.4 and p27AS2.8); these clones are described elsewhere (Baldassarre et al., 1999 (Baldassarre et al., , 2000 . GDNF failed to induce p27 kip1 up-regulation in GDNF was administered for 7 days at the concentration of 20 ng/ml. c SSEA-3 expression is reported as the percentage of cells positive with respect to total cell number. The data represent the mean (+s.d.) of four dierent experiments in which at least 500 cells were counted p27AS cell clones (a representative clone is shown in Figure 5a ). The analysis of growth rate by¯ow cytometry and BrdU incorporation demonstrated that while GDNF reduced the rate of DNA synthesis in parental cells, it failed to do so in cells in which p27 kip1 up-regulation had been prevented. NT2/D1 cells or p27 kip1 -antisense clones (NT2/D1-p27AS2.4, p27AS2.5 and p27AS2.6) were treated with 20 ng/ml of GDNF for 7 days, labelled with propidium iodide and analysed with FACScan. NT2/D1 cells showed 44% of cells in the S phase compartment, whereas upon GDNF treatment, cells accumulated in G1 (26% of S phase cells at 7 days and 22% at 15 days of treatment, respectively). Conversely, in all three p27 kip1 -antisense clones analysed, a larger fraction of cells remained in the S-phase compartment (49, 40, 46% respectively). The results are summarized in Table  1 and a representative experiment is shown in Figure  5c . Similar results were obtained with the analysis of BrdU incorporation (not shown).
GDNF-induced SSEA-3 down-regulation (28% of GDNF-treated NT2/D1 cells stained for SSEA-3) was impaired if p27 kip1 expression was suppressed (58 and 73% of p27AS2.4 and p27AS2.6 cells stained for SSEA-3, respectively) (Table 1 and Figure 5c ). Finally, the RET-MEN2A construct failed to induce p27 kip1 and to reduce BrdU incorporation and SSEA-3 expression when transiently transfected into NT2/D1-p27AS cells (Figure 6 ). The results are summarized in Table 2 . Thus, the failure to up-regulate p27 kip1 leads to the failure of NT2/D1 cells to respond properly to the growth-arresting and dierentiating signals elicited by RET.
GDNF up-regulates p27 kip1 expression in different cellular model of neuronal differentiation
We also investigated whether the GDNF/RET system regulated the expression of p27 kip1 in other cellular model of neuronal dierentiation. As a cellular model (Figure 7a,b) .
These results indicate that the up-regulation of p27 kip1 protein levels represents a common molecular target whereby the GDNF/RET system regulates the growth and the terminal dierentiation of cells that dierentiate along the neuronal pathway.
Discussion
Neuronal dierentiation is closely coupled to cessation of cell proliferation, suggesting that the antimitotic activity of neurotrophic factors may be necessary for dierentiation. Although it is well-established that ligands of the GDNF family commit neuronal cells to dierentiate, the molecular pathways mediating this eect are largely unknown.
In this study we have used the human NT2/D1 cell line as a model system to study the eects exerted by GDNF. NT2/D1 cells exhibit the properties of pluripotential stem cells and terminally dierentiate into neurons upon treatment with RA . We report that GDNF induces growth inhibition and a corresponding down-regulation of the proliferation-associated SSEA-3 antigen in NT2/D1 cells. Remarkably, GDNF reduces the growth of NT2/ D1 cells in vitro and in vivo. Treatment of NT2/D1 cells with GDNF markedly reduced the fraction of NT2/D1 cells in the S phase and tumorigenicity in nude mice. However, GDNF treatment did not drive NT2/D1 cells to a complete dierentiated phenotype: upon GDNF treatment, NT2/D1 cells neither developed neuronal processes nor up-regulated the neuron-speci®c A2B5 marker.
The eects exerted by GDNF in NT2/D1 cells are mediated by activation of RET kinase; indeed, RET signalling is both necessary and sucient to exert both growth inhibition and SSEA-3 down-regulation. These eects are markedly reduced if RET activity is suppressed by a dominant negative mutant; conversely, the constitutively active RET-MEN2A allele mimicks the eects exerted by exogenously administered GDNF.
Previous work from our laboratory has shown that the CDK inhibitor p27 kip1 is a key factor for the physiology of NT2/D1 cells at a critical switch point where growth-arrest is followed by dierentiation (Baldassarre et al., 1999 (Baldassarre et al., , 2000 . Here we show that p27 kip1 is also a pivotal eector of GDNF/RETmediated signalling. In fact, p27 kip1 expression was up-regulated by RET; as a result, p27 kip1 associated with cyclin-CDK complexes and impaired their kinase activity. On the other hand, expression of an antisense construct for p27 kip1 virtually abrogated the eects of GDNF and/or RET-MEN2A on cell cycle progression. These ®ndings are consistent with the notion that high levels of p27 kip1 protein are associated with terminally dierentiated neurons (Durand et al., 1997 (Durand et al., , 1998 . Neuronal dierentiation has been correlated with loss of CDK activity (Yan and Zi, 1995; Park et al., 1996) . Inhibition of CDK activity is mediated by upregulation of CDK inhibitors in neuroblastoma cells treated with dierentiating agents (Kranenburg et al., 1995) . Our results indicate that in NT2/D1 cells, RETmediated up-regulation of p27 kip1 is likely responsible for the loss of CDK activity. Interestingly, activation of the RET pathway induces the expression of p27 kip1 protein in parallel with growth inhibition also in other model systems (such as the human neuroepithelioma SK-N-MC cells and the rat pheochromocytoma cells). These results strongly suggest that this cyclin-dependent kinase inhibitor represents a common molecular target whereby the GDNF/RET system regulates the growth and the terminal dierentiation of cells that dierentiate along the neuronal pathway.
Similarly, the dierentiative response of PC12 cells to NGF depends on growth arrest mediated by a decline in the activity of G1 CDK. In this model kip1 association to CDK4; middle panel, CDK4 levels in the corresponding immunoprecipitates; lower panel, CDK4 activity using recombinant GST-RB peptide as substrate. As a control non-immune rabbit serum (NRS) was used for immunoprecipitation. Red Ponceau staining of the ®lters was performed in every experiment to ensure uniform protein loading system, another cyclin-dependent kinase inhibitor of the cip/Kip family, p21 cip1 rather than p27 kip1 , mediates growth arrest and dierentiation in response to NGF Erhardt and Pittman, 1998; Qu et al., 1998; van Grunsven et al., 1996; Yan and Zi, 1995) . Thus it appears that the cyclin-dependent kinase inhibitors of the cip/Kip family play a critical role in the regulation of growth and terminal dierentiation induced by neurotrophins.
The pathway(s) leading to p27 kip1 accumulation after RET stimulation remain(s) to be established. It has been demonstrated that NGF-triggered p21 cip1 accumulation is mediated by transcriptional activation of the p21 cip1 promoter (Marshall, 1995; Billon et al., 1996) . In contrast, several lines of evidence indicate that p27 kip1 levels are regulated by RA at the posttranscriptional rather than transcriptional levels in neuroblastoma (Borriello et al., 2000) and in NT2/D1 cells (Baldassarre et al., 2000) . The currently accepted model indicates that p27 kip1 is phosphorylated on threonine 187 and is targeted to ubiquitin-mediated degradation at the G1/S transition Montagnoli et al., 1999) . Our results suggest that in NT2/D1 cells, the expression of p27 kip1 is essentially regulated at post-transcriptional level. In fact, neither RA nor GDNF increases steady-state levels of p27 kip1 mRNA. This conclusion is in agreement with the observation that in NT2/D1 cells the ubiquitin/ proteasome pathway is involved in the degradation of the p27 kip1 protein. In conclusion, our results suggest that the GDNF/ RET pathway induces proliferative inhibition in NT2/ D1 cells and that p27 kip1 represents a key molecular factor in GDNF-dependent pathways regulating growth and dierentiation.
Materials and methods

Plasmids and antibodies
The RET plasmid encoding the MEN2A-associated mutant (C634Y) cloned in the LTR vector is described elsewhere . The RET(DK) mutant was generated by recombinant PCR by deleting the entire kinase domain of RET (residues 719 ± 1072) and fusing the product in-frame at the C-terminal with the FLAG octapeptide (DYKDDDDK). The mutation was con®rmed by DNA sequencing and the tagged RET(DK) mutant was cloned in the LTR vector. The expression vector encoding the GFRa1 construct was a gift from Dr S Jing). Polyclonal Ret antibodies were raised against the kinase domain of the protein . Anti-phosphotyrosine antibodies (4G10) were from Upstate Biotechnology Inc. (Lake Placid, NY, USA). The other antibodies were obtained from Santa Cruz (Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA) (CDK4), Pharmingen (San Diego, CA, USA), and Transduction Laboratories (Lexington, KY, USA) (anti-p27 and anti-CDK2).
Cell culture and treatments
The NT2/D1 cell line was grown in Dulbecco's modi®ed Eagle medium (DMEM) supplemented with 10% of heat inactivated foetal calf serum (FCS), 4 mM glutamine, 100 U/ ml penicillin and 10 mg/ml streptomycin (GIBCO ± BRL, PA, USA). NT2/D1 cells were transfected as described (Baldassarre et al., 1999) . COS-7 cells were grown in DMEM supplemented with 10% FCS and transfected with the calcium phosphate technique. GDNF was from Alomone labs (Jerusalem, Israel) and was solubilized in serum-free DMEM.
Immunoprecipitation and kinase assay
Cells were scraped and lysed in cold NP-40 buer (0.5% NP-40, 50 mM HEPES pH 7.2; 50 mM NaCl, 5 mM EDTA) supplemented with a cocktail of protease inhibitors. Proteins were separated and transferred to nitrocellulose ®lters membranes (Hybond C, Amersham Inc., Bucks, UK) and revealed by the speci®c antibody using enhanced chemiluminescence (ECL, Amersham Inc.). For immunoprecipitations, 500 mg of proteins were immunoprecipitated twice with 1 ± 2 mg of the indicated antibodies for 60 min at 48C. Immunoprecipitated proteins were collected on protein A/ G-Sepharose (Santa Cruz), resolved on polyacrylamide denaturing gels, transferred to nitrocellulose ®lters and incubated with primary antibodies. One-tenth of immunoprecipitates were resuspended in kinase buer (20 mM MOPS, pH 7.2, 25 mM b-glycerol phosphate, 5 mM EGTA, 1 mM sodium ortovanadate, 1 mM DTT, 7.5 mM MgCl 2 , 50 mM ATP, 10 mCi of [g-32 P]dATP) supplemented with 2 mg of histone H1 (Upstate Biotechnology) or 1 mg of GST-pRB (Santa Cruz Inc.) and incubated for 15 min at 308C. Reactions were stopped and radioactive phosphate incorporation was determined by SDS ± PAGE. Analysis of the dried gel was performed using a Phosphorimager (GS-525 Biorad) interfaced with a Hewlett-Packard computer.
Immunofluorescence analysis
Bromodeoxyuridine (BrdU) was added to the culture medium to a ®nal concentration of 10 mM and the labelling procedure was carried out for 1 h. BrdU incorporation assay was performed using the BrdU labelling and detection kit (Boehringer Mannheim Biochemicals). To analyse the expression of SSEA-3 and A2B5, cells were incubated with primary antibody followed by rhodamine-conjugated antimouse IgGs. Fluorescence was analysed by an epi¯uorescent microscope that discriminates between rhodamine (SSEA-3 and A2B5) and green¯uorescent protein (EGFP).
Flow-cytometric analysis
NT2/D1 cells were analysed for DNA content and expression of cell surface antigens as previously described (Baldassarre et al., 1999) . Cells were collected and washed in PBS. DNA was stained with propidium iodide (PI) (50 mg/ml) and analysed with FACScan¯ow cytometer (Becton Dickinson, San Jose, CA, USA) interfaced with a Hewlett-Packard computer (Palo Alto, CA, USA). Cell cycle analysis was performed by CELL-FIT program (Becton Dickinson). Detection of SSEA-3 or A2B5 mAbs was performed as previously described (Baldassarre et al., 1999) .
RNA extraction and RT ± PCR
Total RNA was extracted by RNAzol (Tel-Test, Inc., Friendswood, TX, USA), according to standard procedures (Sambrook et al., 1989) . Five micrograms of total RNA, digested with RNAse-free DNAse, were reverse transcribed using random exanucleotides as primers (100 mM) and 12 units of AMV reverse transcriptase (Promega). Five microliters of cDNA were ampli®ed in a 25 ml reaction mixture containing 1 U of Taq DNA polymerase (Boehringer), 0.4 mM dNTP, 2.0 mM MgCl 2 , 0.2 mM of each primer. The PCR ampli®cation was performed for 23 cycles (948C for 30 min, 558C for 30 min and 728C for 30 min), using the Protocol Thermal Cycler (AMS Biotechnology). Primers were designed to speci®cally amplify the transcripts of the mouse and human p27 gene (forward primer: 5'-ATGT-CAAACGTGCGAGTGTC-3'; reverse primer 5'-TTACGT-TTGACGTCTTCTGAGGCC-3'). In addition, a set of primers speci®c for the GAPDH gene (forward primer: 5'-ACATGTTCCAATATGATTCC-3' and reverse primer: 5'-TGGACTCCACGACGTACTCAG-3') was added to each reaction as internal control for the amount of cDNA tested. The PCR products were separated on 1.5% agarose gel, and transferred to nylon membranes. The membranes were hybridized with a full-length p27 kip1 cDNA fragment according to standard procedures (Sambrook et al., 1989) . The random priming procedure was used for labelling (Sambrook et al., 1989) . The relative level of p27 kip1 was assessed by comparison with the level of GAPDH in the same sample and quanti®ed by Phosphorimager densitometric scanning. The values were normalized with the corresponding value of GAPDH expression.
